The FDA and CMS have signed a memorandum of understanding that will allow for routine sharing of data between the two agencies and subject medical devices to premarket evaluation and a Medicare coverage determination process simultaneously. "Such an approach could reduce the time from FDA approval to CMS coverage and payment for some devices," said Jeff Shuren, director of the FDA's Center for Devices and Radiological Health.

Related Summaries